Article Abstract

Epidermal growth factor as a prognostic biomarker in chronic kidney diseases

Authors: Yoshitaka Isaka


Chronic kidney disease (CKD), a major global public health problem (1), affects approximately 10% of the adult population worldwide (2). CKD increases the risk of all-cause mortality, cardiovascular disease, and the progression to end stage kidney diseases (1).


  • There are currently no refbacks.

Article Options

Download Citation